Innovation Ventures Seminars are quarterly events designed to bring useful and timely information to Cincinnati Children’s Innovators on topics related to intellectual property, commercialization and entrepreneurship.
In the Seminar Series you will have an opportunity to learn and hear from the perspective of Industry, Inventors, and Investors.
October 18, 2018, at Noon - Location: D4.65 HI Conference Room
Seminar with Inventor
Ryan Moore, MD, Assistant Professor Cardiology
Please join Ryan Moore, MD as he shares progress on the Heart VR/AR Surgical Planning project, his experience working with Innovation Ventures, and what has taken him and the team to make the project a success.
To RSVP contact Guillermina Gomez
April 19, 2018
Gavi Begtrup, PhD, Chief Executive Officer, Eccrine Systems, Inc
Gavi Begtrup discussed how Eccrine Systems is integrating developments in microfluidics, miniaturized electronics, and electrochemical biosensors to move diagnostics from the lab to the body. Dr. Begtrup discussed Eccrine's first product, a heat stress and dehydration avoidance monitor for the industrial workforce, as well as future applications for non-invasive, continuous monitoring of biomarkers in sweat to improve health across medicine, industry, military, and sports.
April 19, 2017
Joseph Sypek, PhD, Shire
Dr. Sypek and Cincinnati Children's representatives released the 2017 Cincinnati Children's and Shire Research Alliance Request for Proposals (RFP).
May 4, 2017
Mike Bishop, Director, Medicinal Chemistry, Discovery Partnerships with Academia (DPAc), GSK
Dr. Bishop provided an overview of DPAc. Comprised of leading GSK scientists with a broad range of backgrounds across numerous therapeutic areas and drug target classes, the DPAc team evaluates, establishes, and co-leads research programs with leading academia researchers to deliver new medicines - pairing the best of academic with GSK's drug expertise to translate innovative research into medicines.
June 26, 2017
Jan Rosenbaum, PhD, Airway
Jan Rosenbaum and Innovation Ventures representatives discussed the value in drug development and today's investment climate for Biotech companies and how value is defined.
No past events, please refer to our upcoming seminars!
September 19, 2018
Mike Myers, Senior Director, Due Diligence - Lilly Research Labs
Mike Myers provided a perspective on external innovation. Mike shared: Lilly's priorities, understanding the external innovation environment, framing the problem, and Lilly's approach to external innovation.
For any questions or additional information, please contact Guillermina Gomez.